Mark Eisner's Insider Trades & SAST Disclosures
Mark Eisner's most recent trade in FibroGen Inc was a trade of 2,042 Common Stock done at an average price of $17.0 . Disclosure was reported to the exchange on June 7, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Mark Eisner.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| FibroGen Inc | Mark Eisner | EVP, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 17.04 per share. | 07 Jun 2023 | 2,042 | 162,862 (0%) | 0% | 17.0 | 34,792 | Common Stock |
| FibroGen Inc | Mark Eisner | EVP, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 18.83 per share. | 02 Jun 2023 | 1,090 | 164,904 (0%) | 0% | 18.8 | 20,525 | Common Stock |
| FibroGen Inc | Mark Eisner | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 18.78 per share. | 04 Apr 2023 | 9,182 | 165,994 (0%) | 0% | 18.8 | 172,473 | Common Stock |
| FibroGen Inc | Mark Eisner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2023 | 12,451 | 185,316 (0%) | 0% | 0 | Common Stock | |
| FibroGen Inc | Mark Eisner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2023 | 7,732 | 172,865 (0%) | 0% | 0 | Common Stock | |
| FibroGen Inc | Mark Eisner | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 21.16 per share. | 08 Mar 2023 | 7,363 | 165,133 (0%) | 0% | 21.2 | 155,771 | Common Stock |
| FibroGen Inc | Mark Eisner | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 20.20 per share. | 08 Mar 2023 | 6,255 | 175,176 (0%) | 0% | 20.2 | 126,334 | Common Stock |
| FibroGen Inc | Mark Eisner | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 20.20 per share. | 08 Mar 2023 | 3,885 | 181,431 (0%) | 0% | 20.2 | 78,467 | Common Stock |
| FibroGen Inc | Mark Eisner | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 21.87 per share. | 02 Mar 2023 | 1,187 | 172,496 (0%) | 0% | 21.9 | 25,960 | Common Stock |
| FibroGen Inc | Mark Eisner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
| FibroGen Inc | Mark Eisner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 32,500 | 173,683 (0%) | 0% | 0 | Common Stock | |
| FibroGen Inc | Mark Eisner | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.04 per share. | 01 Dec 2022 | 1,084 | 141,183 (0%) | 0% | 15.0 | 16,303 | Common Stock |
| FibroGen Inc | Mark Eisner | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.01 per share. | 30 Sep 2022 | 6,777 | 142,267 (0%) | 0% | 13.0 | 88,169 | Common Stock |
| FibroGen Inc | Mark Eisner | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.09 per share. | 01 Sep 2022 | 756 | 149,044 (0%) | 0% | 13.1 | 9,896 | Common Stock |
| FibroGen Inc | Mark Eisner | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.61 per share. | 01 Jun 2022 | 1,141 | 149,800 (0%) | 0% | 9.6 | 10,965 | Common Stock |
| FibroGen Inc | Mark Eisner | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.62 per share. | 01 Mar 2022 | 756 | 157,383 (0%) | 0% | 13.6 | 10,297 | Common Stock |
| FibroGen Inc | Mark Eisner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| FibroGen Inc | Mark Eisner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2022 | 60,000 | 158,139 (0%) | 0% | 0 | Common Stock | |
| FibroGen Inc | Mark Eisner | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.82 per share. | 03 Jan 2022 | 7,043 | 98,139 (0%) | 0% | 14.8 | 104,377 | Common Stock |
| FibroGen Inc | Mark Eisner | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.65 per share. | 01 Dec 2021 | 4,338 | 105,182 (0%) | 0% | 12.7 | 54,876 | Common Stock |
| FibroGen Inc | Mark Eisner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2021 | 74,520 | 109,520 (0%) | 0% | 0 | Common Stock | |
| FibroGen Inc | Mark Eisner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2021 | 44,520 | 44,520 | - | - | Stock Option (Right to Buy) | |
| FibroGen Inc | Mark Eisner | Incoming Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2020 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| FibroGen Inc | Mark Eisner | Incoming Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2020 | 35,000 | 35,000 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges